Decreased S100-beta protein in schizophrenia: preliminary evidence
- 15 June 2000
- journal article
- Published by Elsevier BV in Schizophrenia Research
- Vol. 43 (2-3), 91-95
- https://doi.org/10.1016/s0920-9964(99)00146-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injuryJournal of Neurosurgery, 1996
- Phospholipase A2 and the hypofrontality hypothesis of schizophreniaProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's diseaseArchiv Fur Psychiatrie Und Nervenkrankheiten, 1996
- Intracerebroventricular injection of phospholipase A2 inhibits apomorphine-induced locomotion in ratsPsychiatry Research, 1995
- Increased platelet phospholipase A2 activity in schizophreniaSchizophrenia Research, 1995
- Decreased phospholipase A2 activity in Alzheimer brainsBiological Psychiatry, 1995
- Chapter 39: S100β and serotonin: a possible astrocytic-neuronal link to neuropathology of Alzheimer's diseasePublished by Elsevier BV ,1992
- Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 1989
- Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapyBiological Psychiatry, 1987
- A negative symptom rating scalePsychiatry Research, 1985